References
- Ronkainen J, Ala-Houhala M, Huttunen NP, Jahnukainen T, Koskimies O, Ormala T, Nuutinen M. Outcome of Henoch-Schonlein nephritis with nephritic-range proteinuria. Clin Nephrol 2003;60:80-4. https://doi.org/10.5414/CNP60080
- Yildiz B, Kural N, Aydin B, Colak O. Increased serum levels of insulinlike growth factor (IGF)-1 and IGF-binding protein-3 in Henoch-Schonlein purpura. Tohoku J Exp Med 2008;214:333-40. https://doi.org/10.1620/tjem.214.333
- Ru L, Abudouhaer A, Guo YF. Clinical significance of serum levels of IGF-1 and IGFBP-3 in children with Henoch-Schonlein purpura or Henoch-Schonlein purpura nephritis. Zhongguo Dang Dai Er Ke Za Zhi 2013;15:1009-13.
- Lin CY, Yang YH, Lee CC, Huang CL, Wang LC, Chiang BL. Thrombopoietin and interleukin-6 levels in Henoch-Schonlein purpura. J Microbiol Immunol Infect 2006;39:476-82.
- Ha TS. The role of tumor necrosis factor-alpha in Henoch-Schonlein purpura. Pediatr Nephrol 2005;20:149-53. https://doi.org/10.1007/s00467-004-1726-3
- Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, et al. The American College of Theumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthritis Rheum 1990;33:114-21.
- Saulsbury FT. Epidermiology of Henoch-Schonlein purpura. Cleve Clin J Med 2002;69:187-9.
- Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Holtta T, et al. Renal manifestations of Henoch-Schonlein purpura in a 6-month prospective study of 223 children. Arch Dis Child 2010;95:877-82. https://doi.org/10.1136/adc.2009.182394
- Kawasaki Y, Ono A, Ohara S, Suzuki Y, Suyama K, Suzuki J, et al. Henoch-Schonlein purpura nephritis in childhood: pathogenesis, prognostic factors and treatment. Fukushima J Med Sci 2013;59:15-26. https://doi.org/10.5387/fms.59.15
- Shin JI, Park JM, Shin YH, Lee JS, Jeong JH, Kim HS. Serum IgA/C3 ratio may be a useful marker of disease activity in severe Henoch-Schonlein nephritis. Nephron Clin Pract 2005;1012:72-8.
-
Balaram SK, Agrawal DK, Edwards JD. Insulin like growth factor-1 activates nuclear factor-
${\kappa}B$ and increases transcription of the intercellular adhesion molecule-1 gene in endothelial cells. Cardiovasc Surg 1999;7:91-7. https://doi.org/10.1016/S0967-2109(98)00044-1 - Tonshoff B, Kaskel FJ, Moore LC. Effects of insulin-like growth factor I on the renal juxtamedullary microvasculature. Am J Physiol Renal Physiol 1998;274:120-8.
- Rossert J, Terraz-Durasnel C, Brideau G. Growth factors, cytokines, and renal fibrosis during the course of diabetic nephropathy. Diabetes Metab 2000;26(suppl 4):16-24.
- Oldroyd SD, Miyamoto Y, Moir A, Johnson TS, El-Nahas AM, Haylor JL. An IGF-I antagonist does not inhibit renal fibrosis in the rat following subtotal nephrectomy. Am J Physio Renal Physiol 2006;290:695-702. https://doi.org/10.1152/ajprenal.00058.2005
- Ece A, Kelekci S, Kocamaz H, Hekimoglu A, Balik H, Yolbas I, et al. Antioxidant enzyme activities, lipid peroxidation, and total antioxidant status in children with Henoch-Schonlein purpura. Clin Rheumatol 2008;27:163-9. https://doi.org/10.1007/s10067-007-0671-5
- Chen T, Guo ZP, Zhang YH, Gao Y, Liu HJ, Li JY. Elevated serum heme oxygenase-1 and insulin-like growth factor-1 levels in patients with Henoch-Schonlein purpura. Rheumatol Int 2011;31:321-6. https://doi.org/10.1007/s00296-009-1254-3
- Ge W, Wang HL, Sun RP. Pentraxin 3 as a novel early biomarker for the prediction of Henoch-Schonlein purpura nephritis in children. Eur J PEdiatr 2014;173:213-8. https://doi.org/10.1007/s00431-013-2150-0